Ethyl bromoacetate → HCID 14975959, compound

HRID 1378741Notes

Reaction equation

HRID 1378741 reaction equation
CC(C)([O-])C.[K+].[C:7]([O:11][C:12]([NH:14][C:15]1[C:20]([N+:21]([O-:23])=[O:22])=[CH:19][CH:18]=[CH:17][C:16]=1[F:24])=[O:13])([CH3:10])([CH3:9])[CH3:8].Br[CH2:26][C:27]([O:29][CH2:30][CH3:31])=[O:28]>C1COCC1>[CH2:30]([O:29][C:27](=[O:28])[CH2:26][N:14]([C:12]([O:11][C:7]([CH3:10])([CH3:8])[CH3:9])=[O:13])[C:15]1[C:20]([N+:21]([O-:23])=[O:22])=[CH:19][CH:18]=[CH:17][C:16]=1[F:24])[CH3:31]

Participants

5

Procedure

Potassium tert-butoxide (1M in THF, 8,67 ml) is added (dropwise over 5 min) to a solution of N-(tert-butyloxycarbonyl)-2-fluoro-6-nitroaniline (XIX, EXAMPLE 21, 1.85 g) in THF (15 ml) cooled at 0°. After 20 min, ethyl bromoacetate (0.96 ml) is added dropwise over several minutes. The ice bath is removed and the reaction is stirred for 2 h, after which it is partitioned between ethyl acetate, aqueous sodium bicarbonate and saline. The phases are separated, the organic phase is dried over magnesium sulfate and concentrated to give the title compound, NMR (CDCl3) 1.26, 1.35, 1.50, 3.98, 4.10, 4.20, 4.42, 4.45, 7.42 and 7.39 δ.

Workup

  1. temperaturecooled at 0°
  2. customThe ice bath is removed
  3. customafter which it is partitioned between ethyl acetate, aqueous sodium bicarbonate and saline
  4. customThe phases are separated
  5. dry with materialthe organic phase is dried over magnesium sulfate
  6. concentrationconcentrated

Sources & evidence

ORD record
ord-8a92a1557a73429693880837b4dcf890
Source dataset
uspto-grants-1997_09
Patent number
US05668282

Reaction notes

Loading…